1. A banking organization must account for the dependence between exposure and the counterparty's credit quality in regulatory CVA calculations for transactions with a significant level of dependence. 
2. For margined counterparties, only financial collateral that qualifies for inclusion in the net independent collateral amount or variation margin amount may be recognized as a risk mitigant. 
3. The simulated paths of discounted future exposure must capture the effects of margining collateral that is recognized as a risk mitigant along each exposure path. 
4. A banking organization must use the same CVA exposure models for financial reporting purposes and regulatory CVA calculations, adjusted to meet the requirements of this section. 
5. For the calculation of the regulatory CVA, a banking organization must recognize netting in the same manner as used for financial reporting purposes.